CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates, ...
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression. Houston Methodist and a ...
Real-world effectiveness and safety with sacituzumab govitecan (SG)–based therapy in metastatic breast cancer (MBC) in China: A multicenter retrospective study. This is an ASCO Meeting Abstract from ...
Metaplastic breast carcinoma, a rare entity (<1% of breast neoplasms), lacks comprehensive spectroscopic characterization. This study aimed to address this gap by providing a qualitative and ...
Rare breast cancers—including but not limited to metaplastic, neuroendocrine, inflammatory, medullary, secretory, and male breast cancers—pose substantial challenges due to limited epidemiological ...
Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression The following represents disclosure ...
Scientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, have made a significant breakthrough in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results